Pulmonary embolism and Brain midline shift

Summary:

Brain midline shift is found among people with Pulmonary embolism, especially for people who are male, 60+ old.

The study analyzes which people have Brain midline shift with Pulmonary embolism. It is created by eHealthMe based on reports of 11 people who have Pulmonary embolism from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Pulmonary embolism?

Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 2,334 drugs and 2,958 conditions by eHealthMe. Check the latest studies of Pulmonary embolism.

What is Brain midline shift?

Brain midline shift is found to be associated with 86 drugs and 214 conditions by eHealthMe. Check the latest studies of Brain midline shift.



On Jul, 29, 2026

11 people who have Pulmonary Embolism and Brain Midline Shift are studied.

Would you have Brain midline shift when you have Pulmonary embolism?

Gender of people who have Pulmonary Embolism and experienced Brain Midline Shift *:

  • female: 50 %
  • male: 50 %

Age of people who have Pulmonary Embolism and experienced Brain Midline Shift *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 10 %
  • 60+: 90 %

Common co-existing conditions for these people *:

  1. Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 9.09%
  2. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 9.09%
  3. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 9.09%
  4. Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 9.09%

Common drugs taken by these people *:

  1. Warfarin Sodium: 2 people, 18.18%
  2. Vancomycin: 1 person, 9.09%
  3. Tamsulosin: 1 person, 9.09%
  4. Simvastatin: 1 person, 9.09%
  5. Rivaroxaban: 1 person, 9.09%
  6. Norvasc: 1 person, 9.09%
  7. Lasix: 1 person, 9.09%
  8. Heparin: 1 person, 9.09%
  9. Fosamax: 1 person, 9.09%
  10. Enoxaparin Sodium: 1 person, 9.09%

Common symptoms for these people *:

  1. Cerebral Haemorrhage (bleeding within the brain): 4 people, 36.36%
  2. Haemorrhage Intracranial (bleeding within the skull): 3 people, 27.27%
  3. Subdural Haematoma (blood collects between the skull and the surface of the brain): 3 people, 27.27%
  4. International Normalised Ratio Increased: 3 people, 27.27%
  5. Unresponsive To Stimuli: 2 people, 18.18%
  6. Headache (pain in head): 2 people, 18.18%
  7. Loss Of Consciousness: 2 people, 18.18%
  8. Hemiparesis (weakness on one side of the body): 2 people, 18.18%
  9. Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 1 person, 9.09%
  10. Dyspnea (difficult or laboured breathing): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Brain midline shift?

- Check whether Brain midline shift is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Brain midline shift:

All the conditions that are associated with Brain midline shift:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Brain midline shift and Pulmonary embolism, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: